Premium
Monocenter study on epidemiology, outcomes, and risk factors of infections in recipients of 166 allogeneic stem cell transplantations during 1 year
Author(s) -
Samek Markus,
Iversen Katharina,
Belmar Campos Cristina,
Berneking Laura,
Langebrake Claudia,
Wolschke Christine,
Ayuk Francis,
Kröger Nicolaus,
Christopeit Maximilian
Publication year - 2020
Publication title -
european journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0902-4441
DOI - 10.1111/ejh.13416
Subject(s) - medicine , leukopenia , neutropenia , cumulative incidence , epidemiology , incidence (geometry) , sepsis , hematopoietic stem cell transplantation , transplantation , risk factor , septic shock , pediatrics , surgery , chemotherapy , optics , physics
Objectives During allogeneic hematopoietic stem cell transplantation (allo‐SCT), infections significantly contribute to morbidity and mortality. A monocentric prospective analysis was performed to assess epidemiology, risk factors, and outcomes of infections during the peri‐transplant period. Methods Data were recorded prospectively using a predefined questionnaire. Results In 2015, 163 consecutive patients, 37.4% female, median age 59 (range 18‐79) years received 166 allo‐SCT. Median duration of leukopenia <10 9 /L was 14.5 days (range 4‐43 days). Fever of unknown origin (FUO) occurred in 118/166 patients (71.1%). Severe sepsis developed in 95, and septic shock developed in 26 patients. Intensive diagnostic workup helped to identify causative microorganisms only in a small number of infectious courses. All but 13 patients needed antibiotic therapy, each according to the standard operating procedures of the department. Cumulative incidence of death by infection after 1 year was 16.6% (95% CI: 11.3‐22.7). The only risk factor for FUO in neutropenia was duration of neutropenia ≥14 days (55.4% vs 85.5%, P < .001). Conclusion Results of an elaborate diagnostic workup of infections in the peri‐transplant period are scarce. Attention to risk factors might help to identify patients at risk for severe infections.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom